NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Isis Pharmaceuticals, Inc. 

Carlsbad Research Center
2292 Faraday Avenue
Carlsbad  California  92008-7208  U.S.A.
Phone: 760-931-9200 Fax: 760-603-4650


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Isis Pharmaceuticals, Inc. (ISIS) Announces Its R&D Webcast Presentation 11/19/2009 11:04:35 AM    More...
Isis Pharmaceuticals, Inc. (ISIS) (JOBS) Cholesterol Drug Meets All Goals of Key Trial 11/17/2009 8:31:13 AM    More...
Genzyme Corporation (GENZ) And Isis Pharmaceuticals, Inc. (ISIS) Announce Data from Mipomersen Phase 3 Trial in hoFH Patients Presented at American Heart Association 11/17/2009 8:23:14 AM    More...
Isis Pharmaceuticals, Inc. (ISIS) Reports Financial Results and Highlights for Third Quarter of 2009 Conference Call Webcast 11/5/2009 9:32:01 AM    More...
Isis Pharmaceuticals, Inc. (ISIS) to Present at the 2009 Canaccord Adams Cardiovascular Conference 11/3/2009 10:33:51 AM    More...
Excaliard, an Isis Pharmaceuticals, Inc. (ISIS) (JOBS) Spinoff With Anti-Scarring Drug, Marches Ahead in Clinical Trials 10/29/2009 7:29:52 AM    More...
Isis Pharmaceuticals, Inc. (ISIS) (JOBS) Diabetes Drug Shows Promise in Mid-Stage 10/22/2009 7:01:32 AM    More...
Isis Pharmaceuticals, Inc. (ISIS) to Present at the 4th Annual BIOCOM Investor Conference 10/20/2009 10:47:15 AM    More...
Isis Pharmaceuticals, Inc. (ISIS) to Present at the 4th Annual JMP Securities Healthcare Focus Conference 9/29/2009 9:35:50 AM    More...
Isis Pharmaceuticals, Inc. (ISIS) Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology 9/10/2009 8:16:51 AM    More...
12345678910...